HMOX1 and Parkinson disease: Previous studies have reported that selective overexpression of HO-1 in astrocytes in GFAP.HMOX1 transgenic mice from 8.5 to 19 months of age lead to the behavioral, neuropathologic, and molecular biological characteristics of parkinsonism (Song et al., 2017).